Ticker
RNXTCompany Name
RENOVORX INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 13.64M | $ 12.31M | 90.26% |
3/31/2025 | $ 16.01M | $ 14.58M | 91.06% |
12/31/2024 | $ 8.12M | $ 7.15M | 88.13% |
9/30/2024 | $ 10.03M | $ 9.56M | 95.33% |
6/30/2024 | $ 12M | $ 11.74M | 97.82% |
3/31/2024 | $ 4.79M | $ 4.39M | 91.67% |
12/31/2023 | $ 1.47M | $ 1.17M | 80.01% |
9/30/2023 | $ 3.52M | $ 3.23M | 91.67% |
6/30/2023 | $ 6.31M | $ 5.95M | 94.3% |
3/31/2023 | $ 4.56M | $ 3.72M | 81.63% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for RENOVORX INC is calculated as follows: CashnEq [ $ 1.8M ] / Assets [ $ 1.91M ]
(=) Cash to Assets [ 93.99% ]
Minimum
Jun 30, 2022
Maximum
Jun 30, 2024
Average
Median
filtered constituents | 3.94K |
---|---|
min | 0% |
max | 40.71% |
average | 9.76% |
median | 6.41% |
std | 9.51% |